Abstract
Rationale & Objective
People with non-dialysis-dependent chronic kidney disease (NDD-CKD) can experience substantial symptoms related to physical and mental health. Patient-reported outcome measures (PROMs) assess these aspects of health-related quality of life (QOL). Using the Kidney Disease Symptom Survey as an example to guide discussions, we sought to understand perspectives of patients and nephrology physicians about using PROMs in routine NDD-CKD care.
Study Design
Individual semi-structured interviews informed by the Theoretical Domains Framework and associated Capability, Opportunity, Motivation model of behavior change.
Setting & Participants
Adults with NDD-CKD and nephrology physicians in the Greater Baltimore-Maryland region.
Analytical Approach
Hybrid inductive-deductive thematic analysis.
Results
We analyzed interview transcripts from 15 nephrology physicians and 21 people with NDD-CKD. Capability to use PROMs was hindered by limited knowledge and skills of nephrology care teams to act on PROM results and manage symptoms. Opportunity to use PROMs was influenced by concerns surrounding environmental resources, including limited accessibility of PROMs to select patient users and limited time available to physicians to review PROMs data. Participants believed that PROMs could guide person-centered care, but motivation to use them was impeded by the uncertain role of nephrology physicians in assessing and managing symptoms and QOL, as well as concerns that PROMs may capture symptoms unrelated to CKD while also lacking sensitivity for key issues relevant to CKD patient care.
Limitations
Impact of clinical practice setting (including the availability of multidisciplinary support) and the views of individual PROM domains was not assessed.
Conclusions
Patient and clinician participants recognized the importance of symptom and QOL assessment in nephrology care. However, behavior changes required to integrate PROMs into routine CKD care may be limited by barriers related to the capability, opportunity, and motivation of users. These findings can inform the development of programs which support PROM implementation.
Index Words: Symptom assessment, quality of life (QOL), person-centered care, implementation
Plain-Language Summary
People with kidney disease often have symptoms, which worsen quality of life. Patient-reported outcome measures (PROMs) are surveys that patients can complete to share how they are feeling with health care teams. We spoke with people with kidney disease and kidney doctors to explore perspectives on using PROMs in kidney care. Participants agreed that PROMs could help focus care on patient needs. Some were uncertain if kidney doctors should be responsible for managing symptoms, especially because some symptoms might not be caused by kidney disease. Some doctors felt they did not have enough time and training to review and act on PROM results. These findings can help guide the creation of programs that enable the use of PROMs in kidney care.
Patient-reported outcome measures (PROMs) capture patients’ experience of disease.1 PROMs have been shown in numerous medical fields to enable person-centered care, such that patients not only have an opportunity to report their symptoms and quality of life (QOL) to clinical care teams, but also so that care teams incorporate patients’ needs into care planning.2, 3, 4 People with chronic kidney disease (CKD) are at risk of high symptom burden and impairments to QOL,5,6 and international guideline bodies have highlighted the need to incorporate symptom and QOL assessment into routine CKD care.7 However, at this time, PROMs are not a routine component of care for people with non-dialysis-dependent CKD (NDD-CKD).
To effectively implement PROMs, perspectives of users must be elucidated and incorporated into implementation planning. Relevant users not only include patients with NDD-CKD who would complete PROMs, but also clinical care teams who would review and act on PROMs data. Furthermore, because the needs of patients and physicians can vary significantly based on their access to resources (eg, socioeconomic status of patients, clinical resources, and care structures for physicians), implementation should be tailored to patient populations and care settings.
In this study, we sought to identify perspectives of patients with NDD-CKD and nephrology physicians in the Greater Baltimore-Maryland region of the United States surrounding use of PROMs. We hypothesized that behavioral determinants would influence users’ perceptions of PROM implementation. We therefore designed our study around the determinant Theoretical Domains Framework (TDF)8 and the associated Capability, Opportunity, Motivation (COM-B) model of behavior change,9,10 which outlines concepts pertaining to capability (the psychological or physical ability to enact a behavior), opportunity (the physical and social environment which enables the behavior), and motivation (reflective and adaptive mechanisms that activate or inhibit the behavior) to use PROMs. Our goal was to use data to develop a framework to guide PROM implementation in routine NDD-CKD care.
Methods
We conducted a qualitative study in which thematic analysis was used to identify determinants of PROM implementation in routine NDD-CKD care. Research was conducted in accordance with consolidated criteria for reporting qualitative research (COREQ) guidelines.11
Setting and Participants
This study was conducted at Johns Hopkins (JH) University, located in the Greater Baltimore-Maryland region. Clinical practices located in this region care for patients who are diverse in race, ethnicity, and socioeconomic status. Patients have variable insurance coverage and access to multidisciplinary/interdisciplinary providers within or external to JH. Multidisciplinary/interdisciplinary care is not a routine component of nephrology care including for patients with advanced kidney disease.
JH Medicine outpatient adult nephrology clinics (located in 4 sites in the Greater Baltimore-Maryland region) distributed an electronic PROM, termed the Kidney Disease Symptom Survey (KDSS), to adult patients with NDD-CKD (stages G3-5) who presented for a follow-up visit from 2022-2024, as previously described.12 Briefly, patients received a request to complete the PROM 7 days before their clinic visit via the electronic patient health portal, with a reminder sent one day before the visit if not completed. Electronic tablets were available for patients to complete the PROM in-person on clinic check in. PROM results were immediately uploaded into the electronic health record (EHR) and were available for physicians to review during clinic visits. Additional reminders or assistance for patients to complete the PROM, or for physicians to review and discuss results, were not provided. Quantitative data surrounding utilization of the KDSS PROM are reported separately.13
We interviewed JH patients with NDD-CKD who had received a request to complete the KDSS (including patients who had not completed it), and nephrology physicians with at least 2 outpatient NDD-CKD clinics per month in the Greater Baltimore-Maryland region (internal and external to JH). Although all JH physicians had received information about KDSS dissemination, utilization of the KDSS was not a requirement for interview participation. Physicians external to JH were not involved in the KDSS intervention.
Sampling Strategy
Nephrology physicians were recruited via an opt-in email distributed by the study team. An effort was made to balance characteristics of physician participants, with purposive sampling used to recruit (1) physicians from JH and non-JH academic centers, and independent practice, and (2) physicians who self-identified as men and women.
Patient participants were selected from a group of JH NDD-CKD patients who participated in a separate questionnaire study,13 which asked for perspectives on the KDSS PROM described above. Purposive sampling was used to recruit participants diverse in age, sex, race, and CKD stage. Individuals who were noted to have significant cognitive limitations or a non-English primary language in their electronic medical record were excluded.
We anticipated some variability in perspectives of physicians working in different practice settings, and of patients with different sociodemographic backgrounds and different degrees of kidney function impairment. We chose initial sample sizes of n = 15 physicians and n = 20 people with NDD-CKD to capture perspectives across these groups,14 with plans to extend recruitment if thematic saturation had not been reached and/or if subsets of participant groups had been underrepresented.
Measures
We identified topics of interest informed by relevant domains of the determinant TDF8 and the associated COM-B model of behavior change9,10 (Table S1). Open-ended semi-structured interview questions were designed to capture perspectives on these topics of interest, as well as others that arose naturally (Item S1-S2). Interviews began by asking participants their perspectives on assessment of patient-reported outcomes broadly and then asked more specific questions on use of PROMs using the KDSS as a reference. Interview questions were pilot-tested within the study team to ensure clarity, and select follow-up probing questions were planned for use as indicated. After the study PI (D.M.P.) reviewed an initial set of 3-5 transcripts for each participant group, the interview guides were revised as needed to ensure clarity of questions and alignment with research objectives.
Procedures
Participants were contacted by a member of the research team (D.S. or J.G.) to obtain consent and schedule an interview. Each participant was emailed or mailed (per participant preference) an informational packet, which included an overview of the KDSS PROM to refer to during the interview.
Interviews were conducted by a female research program coordinator (J.G.) with experience in conducting qualitative interviews. The interviewer discussed the research subject of interest with D.M.P. before conducting interviews, but otherwise had no predetermined biases or assumptions surrounding use of PROMs in CKD care. The interviewer had no established relationship with interview participants. Interviewees were not provided with information about the interviewer. The interviewer ensured that each participant had reviewed and had access to the informational packet, referring to the packet as needed. Field notes were not taken, and repeat interviews were not conducted.
Interviews occurred remotely and were conducted in English. Interviews were audio recorded using the Zoom teleconferencing platform or Virtual Observer software, with recording of audio files only. Audio recordings were submitted to Acolad (Ubiqus) Transcription Services, which provided redacted transcripts for analysis.
Patient participants were remunerated $25 on completion of semi-structured interviews. Physicians were not remunerated. Although transcripts were not returned to participants, a summary of qualitative data was distributed to interview participants for review.
All study activities were approved by the JH Institutional Review Board (IRB00311975).
Analytic approach
We thematically analyzed transcripts and used MaxQDA software to manage data. Three authors (D.M.P., A.P., and S.F.) independently reviewed an initial set of transcripts and collectively refined a codebook. We used a hybrid inductive-deductive strategy to derive codes, which arose naturally as well as those which were guided by interview questions. Codes were organized by relevant TDF and COM-B domains. The final codebook (Table S2) was then applied to all transcripts. Intercoder agreement was calculated for 17 transcripts which were coded by 2 authors, ensuring a kappa statistic > 0.6 (calculated using qualitative software) to represent substantial agreement.15 The remaining transcripts were coded by one coder.
Coded segments were reviewed in aggregate by authors to derive themes. Thematic saturation was defined as the point at which review of additional coded segments did not identify new concepts or relationships between data.16
Results
Participant and Interview Characteristics
We interviewed 15 nephrology physicians and 21 NDD-CKD patients (Table 1). The median interview time was 18 minutes (interquartile range 16-24 minutes).
Table 1.
Characteristics of Interview Participants
| Physician Interviewees (n = 15) | |
|---|---|
| Type of practice | |
| Academic (JH) | 5 (33%) |
| Academic (non-JH) | 5 (33%) |
| Independent practice | 5 (33%) |
| Number of years in practice | |
| < 1 y | 0 (0%) |
| 1 to <5 y | 2 (13%) |
| 5 to <10 y | 4 (27%) |
| 10 to <20 y | 4 (27%) |
| 20+ y | 5 (33%) |
| Frequency of outpatient clinic | |
| 2-3 per mo | 2 (13%) |
| 1-2 per wk | 7 (47%) |
| 3+ per wk | 6 (40%) |
| Patient interviewees (n = 21) | |
|---|---|
| Age, y (mean ± S.D.) | 60 ± 17 |
| Male sex (n %) | 9 (43%) |
| African American race (n %) | 8 (38%) |
| CKD stage | |
| G3a | 3 (14%) |
| G3b | 7 (33%) |
| G4 | 8 (38%) |
| G5 | 3 (14%) |
| Completed KDSS PROM before clinic visit (n %) | 12 (57%) |
Abbreviations: JH, Johns Hopkins; KDSS, kidney disease symptom survey; PROM, patient-reported outcome measure.
Perspectives on Capability
In general, patient participants did not express concern surrounding their capability to complete the PROM. However, nephrology physicians had concerns surrounding capability to act on PROM results. These concerns stemmed from a self-perceived lack of knowledge and skills required to manage symptoms. Nephrology physician participants noted that they are not traditionally trained in symptom assessment and management. Given these limitations, physician participants cited a need for multidisciplinary/interdisciplinary support to help manage symptoms. The potential benefit of a care team member dedicated to patient wellness was supported by a patient participant (Table 2).
Table 2.
Perspectives on Capability to use PROMs in Routine CKD Care
| Theme | Subthemes | Representative Quotations |
|---|---|---|
| Nephrology care teams have limited knowledge and skills to act on PROM results and manage symptoms | Nephrology physicians are not trained in assessment and management of symptoms and QOL. |
|
| Multidisciplinary/-interdisciplinary support is needed to assist both patients and physicians in managing all aspects of PROMs. |
|
Note: Participants are identified by participant type (physician or patient), participant ID, and CKD stage for patients.
Abbreviations: CKD, chronic kidney disease; PROMs, patient-reported outcome measures.
Perspectives on Opportunity
Physician and patient participants felt that the opportunity to use PROMs in routine CKD care would be facilitated by their ease of their completion. Using the KDSS as an example to reference, most participants viewed the PROM as being nonburdensome to patients while capturing many relevant symptoms. One physician participant suggested that screening questions could be used first, which could help avoid asking additional questions to patients who were not experiencing symptoms (Table 3).
Table 3.
Perspectives on Opportunity to use PROMs in Routine CKD Care
| Theme | Subthemes | Representative Quotations |
|---|---|---|
| PROMs are relatively easy to complete. | For most patients, completion of PROMs is not burdensome. |
|
| PROMs may need optimization to be more user friendly. |
|
|
| PROMs should allow multiple potential methods of data collection. | PROMs could be collected in-person on clinic check in. |
|
| Clinic staff could assist patients in completing PROMs. |
|
|
| Review of PROMs data is limited by time constrains of clinic. | Physicians require additional time to review and discuss PROMs data with patients. |
|
| PROMs could be collected before clinic visits via the EHR. |
|
|
| Clinic staff could help ensure that PROMs data are reviewed. |
|
|
| PROM results should be easily understandable. |
|
Participants are identified by participant type (physician or patient), participant ID, and CKD stage for patients.
Abbreviations: CKD, chronic kidney disease; EHR, electronic health record; PROMs, patient-reported outcome measures.
Physician and patient participants noted a need to provide multiple methods of PROM data collection. Although many patients complete the PROM before clinic visits, one patient participant stated a preference to complete it on a tablet in clinic, in which they were more focused on their kidney disease. Electronic PROMs were viewed as being challenging for patients with visual or physical impairments, in which case alternate means of completion (such as a staff-assisted completion) would be beneficial.
Physician participants also noted several concerns surrounding time constraints of clinic. PROM data would add to an already long list of items to review during nephrology clinic visits. Having patients complete PROMs before clinic visits so that results are available during pre-charting, having clinic staff alert physicians to the availability of PROMs data, and using color-coded graphs or summary tables to quickly highlight critical data points (eg, severe symptoms) could help facilitate PROM utilization.
Perspectives on Motivation
Physician and patient participants expressed motivation to use PROMs as a tool to facilitate person-centered care (Table 4). As voiced by participants, PROMs could provide a mechanism for patients to update their care teams on the development of symptoms and QOL impairments, which would have otherwise gone unrecognized. When PROMs provide quantitative scores rather than binary yes/no responses, they could help identify the most significant issues that patients are experiencing. One patient commented that PROMs could therefore help focus clinic visits on the issues that are most important to the patient.
Table 4.
Perspectives on Motivation to use PROMs in Routine CKD Care
| Theme | Subthemes | Representative Quotations |
|---|---|---|
| PROMs can enhance person-centered care. | Symptoms and QOL are pertinent to CKD care. |
|
| PROMs may identify symptoms and impairments which would not have been otherwise recognized. |
|
|
| PROMs can help identify the most significant issues that patients are experiencing. |
|
|
| PROMs could inform medication management and care planning. |
|
|
| PROMs can be used to monitor changes in symptoms and QOL over time. |
|
|
| PROMs can increase patient knowledge of the impact of CKD. |
|
|
| PROMs could enhance patient-physician relationships. |
|
|
| There is uncertainty surrounding the role of nephrology physicians in assessing symptoms and QOL. | CKD care has historically focused on numbers. |
|
| Mental health is not routinely addressed in CKD care. |
|
|
| There is hesitation surrounding the role of PROMs in clinical care. | PROM results may not be actionable. |
|
| Some users prefer to discuss symptoms and QOL through direct conversation. |
|
|
| Patient-physician relationships may impact the shared experience of discussing symptoms and QOL. |
|
|
| There is uncertainty surrounding the sensitivity and specificity of PROMs. | Data captured by PROMs can be non-specific. |
|
| PROMs may not capture all relevant aspects of patient care. |
|
Note: Participants are identified by participant type (physician or patient), participant ID, and CKD stage for patients.
Abbreviations: CKD, chronic kidney disease; PROMs, patient-reported outcome measures; QOL, quality of lift.
Physician and patient participants also identified several mechanisms by which PROMs could inform clinical care. PROMs could identify symptoms, which may be treatable with medications or lifestyle modifications and could also identify opportunities to de-prescribe medications, which could be causing symptoms. PROMs could inform discussions of advanced care and kidney replacement therapy planning, especially because PROMs would facilitate longitudinal monitoring of symptoms and QOL. One physician commented that PROM completion helped highly functional patients recognize the increasing burden of their symptoms and alerted them to the need to plan for kidney replacement therapy. PROMs could also increase patient knowledge/awareness surrounding the impact of their kidney disease. Multiple participants viewed PROMs as a mechanism to enhance patient-physician relationships, enabling patients to feel heard and feel seen, although one physician participant commented that PROMs could make some patients feel that they are just a checklist.
Motivation to use PROMs was limited by uncertainty surrounding the role of nephrology physicians in assessing symptoms, QOL, and mental health. Physician and patient participants cited a historical focus of kidney care on numbers (eg, trends in laboratory assessments). Assessment of symptoms is less traditionally incorporated into nephrology care. One physician participant alluded to not wanting to gain additional expertise in issues such as mental health.
Motivation to use PROMs was further dampened by concerns surrounding their use in clinical care. Physician participants were concerned that if symptoms were not actionable, PROMs would generate unrealistic expectations from patients. Some patient and physician participants expressed a preference to discuss symptoms and QOL through direct conversation, rather than a survey. Patient-physician relationships may also impact the utility of PROMs: one physician participant noted that PROMs might be less necessary for physicians who already have a longstanding relationship with patients, which facilitates an ability to focus on the patient as a whole.
Additionally, physician and patient participants noted that PROMs may capture data which is not specific to kidney disease. Symptoms may be multifactorial and related to patients’ comorbid conditions or other psychosocial factors. Physician and patient participants observed that PROMs may not capture all aspects of the patient experience which are relevant to CKD care, such as issues surrounding medication adherence and burden, social interactions, finances, and social determinants of health.
Data Synthesis
Guided by these data aligned with the COM-B model of behavior change,9,10 we synthesized key factors which participants identified as mechanisms to facilitate use of PROMs in routine NDD-CKD care (Fig 1).
Figure 1.
Synthesis of participant perspectives on mechanisms to facilitate use of PROMs in routine NDD-CKD care. NDD-CKD, non-dialysis-dependent chronic kidney disease; PROMs, patient-reported outcome measures.
Discussion
PROMs capture key aspects of patients’ self-perceived health-related QOL and have been shown to enable person-centered care in other fields of medicine.1,17 PROMs are not routinely used in NDD-CKD care, and their implementation will necessitate behavioral change by users. We interviewed nephrology physicians and people with NDD-CKD to elicit perspectives surrounding the use of PROMs in routine NDD-CKD care, specifically considering the impact of behavioral determinants. We identified key barriers related to the limited capability, opportunity, and motivation for patients and physicians to effectively use PROMs. We found consistency in patient and physician views of the need to support utilization by patients (through multiple methods of PROM collection, including the option of staff-assisted PROM completion) and physicians (through multidisciplinary/interdisciplinary approaches to manage symptoms), and a need to clarify the clinical utility of PROMs, especially if symptoms identified were unrelated to kidney disease. Perspectives were consistent for physicians working in different clinical practice settings, and for patients with different CKD stages. Our findings indicate that addressing these barriers and building the evidence base supporting the benefits of PROMs would support PROM adoption and implementation.
Broadly, our results parallel key issues highlighted in the Patient-Reported Outcomes Tools: Engaging Users & Stakeholders (PROTEUS) consortium guidelines,4 including the need to ensure that all patients have access to PROMs. Our study participants noted a need for multiple methods of PROM completion, outside of electronic PROMs integrated into electronic health records. Electronic PROMs can reduce time and costs required for data collection and analysis, but can exacerbate disparities if unable to be used by patients with limited literacy or access to electronic systems.18 Making electronic equipment available in clinic spaces, as well as providing paper versions of PROMs and ensuring availability in multiple languages, could increase opportunity for patients to use PROMs. In a study of PROMs collected from people on hemodialysis,19 over 60% of kidney care centers reported that patients required carer and/or nurse assistance to complete PROMs. Staff assistance has been shown to improve PROM completion rates in oncology care as well.20 Resources to support staff-assisted PROM completion may therefore be needed during PROM implementation in CKD care.
Implied in these suggestions and PROTEUS guidelines is the need to integrate PROMs throughout clinic workflows, including processes by which care teams review PROMs data. Even after patients complete PROMs, participants identified several barriers to them being integrated into physician workflows and used as part of clinical care. Potential methods to promote physician opportunity to use PROMs included strategies to inform physicians of available results and use of user-friendly visualizations of PROM results (such as traffic-light systems) to help physicians quickly identify and prioritize relevant issues to address with patients.
Our data reflected another issue highlighted in PROTEUS guidelines,4 which is the need for users to agree on the main goals of using PROMs. Many participants highlighted a key motivation of using PROMs to be their potential to inform person-centered care and to serve as an adjunct to traditional management strategies, which parallels findings from Aiyegbusi et al.2 However, other users may lack motivation to implement tools which are not shown to improve traditional patient outcomes such as mortality. Such evidence for PROMs exists in other fields of medicine. For instance, in a randomized clinical trial of patients with metastatic cancer, use of PROM-based systems was associated with increased survival,21,22 and improvements in physical function, symptoms, and QOL.23 Ongoing trials, such as the RePROM study for people with NDD-CKD24 and the SWIFT trial for people treated with dialysis,25 will provide valuable insight into the utility of PROMs for kidney patients. Electronic PROMs applied in pragmatic trials26 may also facilitate data collection surrounding their effectiveness in NDD-CKD patient outcomes. A robust evidence base could generate additional buy-in from PROM users whose motivations are more aligned with changes in clinical outcomes.
In conjunction with integrating PROMs into workflows and ensuring that all users are motivated to use them, resources and education are needed to increase the capability of care teams to act on PROMs data. As noted by our participants, a lack of knowledge and skills to discern the etiology of symptoms and to manage them discourages physicians from reviewing and acting on the results. PROTEUS guidelines state that clinical teams must be equipped to respond to alerts or refer to other support services before integrating PROMs into clinical care.4 Although some guidelines to manage symptoms in people with CKD exist,27,28 related training and educational materials may need to be developed and disseminated to support the capability of care teams to act on PROMs. Such strategies may contribute to a larger culture shift needed to include symptom assessment and management in the routine scope of nephrology practice.29 As noted by our participants, the availability of multidisciplinary/interdisciplinary support to manage symptoms should also be incorporated into implementation planning within each care environment. Multidisciplinary care is commonly available in oncology care settings, which may, in part, explain the more common uptake of PROMs for symptom assessment and monitoring in routine oncology care.30 Specifically, palliative care services have an established role in oncology31,32 and are much less commonly used in nephrology.33
Our study had some limitations. Some interviews were short, but given the narrow scope of the research question, we still achieved saturation of themes presented. Given an interest in implementing PROMs in our local care environment, we exclusively interviewed potential PROM users (patients and nephrology physicians) who received or provided care in the Greater Baltimore-Maryland region. Patient participants were recruited from a group of patients who had consented to participate in a separate questionnaire study,13 although we attempted to mitigate selection bias by selecting interviewee participants who had either completed or not completed the KDSS PROM as part of routine clinical care. Although we would expect our participant characteristics to be translatable to other regions caring for similarly diverse populations, further studies are needed to confirm generalizability. We did not consider the potential impact of multidisciplinary clinics and/or value-based care models, which were not employed for NDD-CKD in our region of practice at the time of this study. We did not include perspectives of other relevant parties, which include care partners of people with NDD-CKD, administrators, support staff, and multidisciplinary care team members. We did not explore the potential impact of incentives and reimbursement policies, which have been previously shown to result in an increase in PROM collection by kidney care teams.19 The KDSS was used as an example PROM to guide discussions, and some perspectives may have applied to the KDSS specifically rather than PROMs generally.
Notable strengths of our study include it being among very few studies reporting perspectives of users on use of PROMs or other assessments of QOL in non-dialysis nephrology care settings.2,34, 35, 36, 37 To our knowledge, it is the first qualitative study to report perspectives on use of PROMs among US patients with NDD-CKD. We framed interview guides with the well-evidenced frameworks pertaining to the use of behavioral change theory, which will help translate concepts identified here to interventions, which can help support the desired behavior of implementing PROMs in routine clinical care.8
In conclusion, although PROMs represent a potential method to deliver person-centered care and to augment traditional clinical management strategies, we identified several barriers that limit the capability, opportunity, and motivation of physicians and patients to use PROMs in routine NDD-CKD care. Interventions guided by the behavior change wheel can be developed and tested for effectiveness in promoting use of PROMs in kidney care settings. Implementation science frameworks can then be used by teams of nephrology physicians, people with NDD-CKD, and multidisciplinary care partners to collaboratively co-design a PROM system, which is tailored to the needs and preferences of users in each clinical setting.
Article Information
Authors’ Full Names and Academic Degrees
Dipal M. Patel, MD, PhD, Aurosikha Panda, MPH, Sani Fatima, MPH, Mary Ann Stephens, PhD, Jessica Gotay-Lehmer, DO, ScM, Danielle Santiago, Deidra C. Crews, MD, ScM, and Kristin A. Riekert, PhD
Authors’ Contributions
Research area and study design: DMP, DCC, and KAR; data acquisition: MAS, JG, and DS; data analysis and interpretation: DMP, AP, SF, DCC, and KRR; mentorship: DCC and KAR. Each author contributed important intellectual content during manuscript drafting or revision and accepts accountability for the overall work by ensuring that questions pertaining to the accuracy or integrity of any portion of the work are appropriately investigated and resolved. AP and SF contributed equally.
Support
Dr. Patel is supported by the Young Investigator Grant of the National Kidney Foundation, the Mid-Atlantic Cardiometabolic Center for Health (National Institutes of Health/ National Institute on Minority Health and Health Disparities grant 1P50MD017348), and the Edward S. Kraus Scholarship Fund. The funders had no direct role in study design; collection, analysis, and interpretation of data; writing the report; or the decision to submit the report for publication.
Financial Disclosure
The authors declare that they have no relevant financial interests.
Acknowledgments
The authors thank all patients and physicians for participation in the research described here.
Data Sharing
Where not available within the article and supplementary materials, the authors agree to make additional redacted data (eg, summaries of qualitative analysis) available on reasonable request, and on completion of a data use agreement with Johns Hopkins University.
Peer Review
Received July 17, 2025 as a submission to the expedited consideration track with 2 external peer reviews. Direct editorial input from an Associate Editor and the Editor-in-Chief. Accepted in revised form October 07, 2025.
Footnotes
Complete author and article information provided before references.
Item S1: Semi-structured interview guide for physician participants.
Item S2: Semi-structured interview guide for patient participants.
Table S1: Mapping of Questions to Theoretical Domains Framework (TDF) and Capability, Opportunity, and Motivation (COM-B) domains.
Table S2: Codebook Used for Qualitative Analysis.
Supplementary Material
Items S1-S2; Tables S1-S2.
References
- 1.Weldring T., Smith S.M. Patient-reported outcomes (PROs) and patient-reported outcome measures (PROMs) Health Serv Insights. 2013;6:61–68. doi: 10.4137/hsi.S11093. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Aiyegbusi O.L., Kyte D., Cockwell P., et al. Patient and clinician perspectives on electronic patient-reported outcome measures in the management of advanced CKD: a qualitative study. Am J Kidney Dis. 2019;74(2):167–178. doi: 10.1053/j.ajkd.2019.02.011. [DOI] [PubMed] [Google Scholar]
- 3.Evans J.M., Glazer A., Lum R., et al. Implementing a patient-reported outcome measure for hemodialysis patients in routine clinical care: perspectives of patients and providers on ESAS-r:renal. Clin J Am Soc Nephrol. 2020;15(9):1299–1309. doi: 10.2215/CJN.01840220. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.The PROTEUS Guide to Implementing Patient-Reported Outcomes in Clinical Practice: A Synthesis of Resources. Prepared by Crossnohere N, Brundage M, Snyder C, and the Advisory Group; 2023. https://theproteusconsortium.org/ [Google Scholar]
- 5.de Goeij M.C.M., Ocak G., Rotmans J.I., Eijgenraam J.W., Dekker F.W., Halbesma N. Course of symptoms and health-related quality of life during specialized pre-dialysis care. PLoS One. 2014;9(4) doi: 10.1371/journal.pone.0093069. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Johansen K.L., Gilbertson D.T., Li S., et al. US Renal Data System 2023 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis. 2024;83:A8–A13. doi: 10.1053/j.ajkd.2024.01.001. [DOI] [PubMed] [Google Scholar]
- 7.KDIGO 2024 Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;105(4s):S117–S314. doi: 10.1016/j.kint.2023.10.018. [DOI] [PubMed] [Google Scholar]
- 8.Atkins L., Francis J., Islam R., et al. A guide to using the theoretical domains framework of behaviour change to investigate implementation problems. Implement Sci. 2017;12(1):77. doi: 10.1186/s13012-017-0605-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Michie S., Atkins L., West R. The Behaviour Change Wheel: A Guide to Designing Interventions. Silverback. 2014 [Google Scholar]
- 10.Michie S., van Stralen M.M., West R. The behaviour change wheel: A new method for characterising and designing behaviour change interventions. Implement Sci. 2011;6(1):42. doi: 10.1186/1748-5908-6-42. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Tong A., Sainsbury P., Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349–357. doi: 10.1093/intqhc/mzm042. [DOI] [PubMed] [Google Scholar]
- 12.Patel D.M., Thavarajah S., Bitzel J., et al. Dissemination and early experiences of an electronic patient-reported outcome measure in nephrology clinic. Clin J Am Soc Nephrol. 2023;18(9):1204–1206. doi: 10.2215/CJN.0000000000000209. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Patel D.M., Han D., Stephens M.A.C., et al. Real-world experience with an electronic patient-reported outcome measure (ePROM) in care of patients with non-dialysis-dependent chronic kidney disease. Clin J Am Soc Nephrol. 2025;20(9):1226–1235. doi: 10.2215/cjn.0000000770. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Vasileiou K., Barnett J., Thorpe S., Young T. Characterising and justifying sample size sufficiency in interview-based studies: systematic analysis of qualitative health research over a 15-year period. BMC Med Res Methodol. 2018;18(1):148. doi: 10.1186/s12874-018-0594-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.McHugh M.L. Interrater reliability: the kappa statistic. Biochem Med (Zagreb) 2012;22(3):276–282. [PMC free article] [PubMed] [Google Scholar]
- 16.Rahimi S., khatooni M. Saturation in qualitative research: an evolutionary concept analysis. Int J Nurs Stud Adv. 2024;6 doi: 10.1016/j.ijnsa.2024.100174. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Mejdahl C.T., Schougaard L.M.V., Hjollund N.H., Riiskjær E., Lomborg K. Patient-reported outcome measures in the interaction between patient and clinician – a multi-perspective qualitative study. J Patient-Rep Outcomes. 2020;4(1):3. doi: 10.1186/s41687-019-0170-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Meirte J., Hellemans N., Anthonissen M., et al. Benefits and disadvantages of electronic patient-reported outcome measures: systematic review. JMIR Perioper Med. 2020;3(1) doi: 10.2196/15588. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Morton R.L., Lioufas N., Dansie K., et al. Use of patient-reported outcome measures and patient-reported experience measures in renal units in Australia and New Zealand: a cross-sectional survey study. Nephrology (Carlton) 2020;25(1):14–21. doi: 10.1111/nep.13577. [DOI] [PubMed] [Google Scholar]
- 20.Flannery M.A., Mohile S., Culakova E., et al. Completion of patient-reported outcome questionnaires among older adults with advanced cancer. J Pain Symptom Manage. 2022;63(2):301–310. doi: 10.1016/j.jpainsymman.2021.07.032. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Basch E., Deal A.M., Dueck A.C., et al. Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. JAMA. 2017;318(2):197–198. doi: 10.1001/jama.2017.7156. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Denis F., Lethrosne C., Pourel N., et al. Randomized trial comparing a web-mediated follow-up with routine surveillance in lung cancer patients. J Natl Cancer Inst. 2017;109(9) doi: 10.1093/jnci/djx029. [DOI] [PubMed] [Google Scholar]
- 23.Basch E., Deal A.M., Kris M.G., et al. Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol. 2016;34(6):557–565. doi: 10.1200/JCO.2015.63.0830. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Kyte D., Bishop J., Brettell E., et al. Use of an electronic patient-reported outcome measure in the management of patients with advanced chronic kidney disease: the RePROM pilot trial protocol. BMJ Open. 2018;8(10) doi: 10.1136/bmjopen-2018-026080. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Greenham L., Bennett P.N., Dansie K., et al. The symptom monitoring with feedback trial (SWIFT): protocol for a registry-based cluster randomised controlled trial in haemodialysis. Trials. 2022;23(1):419. doi: 10.1186/s13063-022-06355-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Samal L., Hemmelgarn B., Dember L.M. Use of pragmatic trials to improve implementation of best practices for CKD. Am J Kidney Dis. 2024;84(5):651–654. doi: 10.1053/j.ajkd.2024.06.008. [DOI] [PubMed] [Google Scholar]
- 27.Kalantar-Zadeh K., Lockwood M.B., Rhee C.M., et al. Patient-centred approaches for the management of unpleasant symptoms in kidney disease. Nat Rev Nephrol. 2022;18(3):185–198. doi: 10.1038/s41581-021-00518-z. [DOI] [PubMed] [Google Scholar]
- 28.Rhee C.M., Edwards D., Ahdoot R.S., et al. Living well with kidney disease and effective symptom management: consensus conference proceedings. Kidney Int Rep. 2022;7(9):1951–1963. doi: 10.1016/j.ekir.2022.06.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Brown M., Hole B., Brennan F., Vallath N., Davison S.N. Kidney supportive care: every nephrologist’s business. Kidney Int. 2025;107:582–586. doi: 10.1016/j.kint.2025.01.010. [DOI] [PubMed] [Google Scholar]
- 30.Selby P., Popescu R., Lawler M., Butcher H., Costa A. The value and future developments of multidisciplinary team cancer care. Am Soc Clin Oncol Educ Book. 2019;(39):332–340. doi: 10.1200/edbk_236857. [DOI] [PubMed] [Google Scholar]
- 31.Agarwal R., Epstein A.S. The role of palliative care in oncology. Semin Intervent Radiol. 2017;34(4):307–312. doi: 10.1055/s-0037-1608702. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Getie A., Yilak G., Ayenew T., Amlak B.T. Palliative care utilisation globally by cancer patients: systematic review and meta-analysis. BMJ Support Palliat Care. 2025;15(3):291–299. doi: 10.1136/spcare-2024-005000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Metzger M., Yoder J., Fitzgibbon K., Blackhall L., Abdel-Rahman E. Nephrology and palliative care collaboration in the care of patients with advanced kidney disease: results of a clinician survey. Kidney Med. 2021;3(3):368–377.e1. doi: 10.1016/j.xkme.2021.01.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Ducharlet K., Philip J., Kiburg K., Gock H. Renal supportive care, palliative care and end-of-life care: perceptions of similarities, differences and challenges across Australia and New Zealand. Nephrology (Carlton) 2021;26(1):15–22. doi: 10.1111/nep.13787. [DOI] [PubMed] [Google Scholar]
- 35.Hull K.L., Reast J., Clair C., et al. UK survey of patient and caregiver perspectives on the impact of chronic kidney disease-associated anaemia. BMJ Open. 2024;14(8) doi: 10.1136/bmjopen-2024-087802. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Meuleman Y., van der Bent Y., Gentenaar L., et al. Exploring patients' perceptions about chronic kidney disease and their treatment: a qualitative study. Int J Behav Med. 2024;31(2):263–275. doi: 10.1007/s12529-023-10178-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Perry L.M., Mohindra N.A., Coughlin A., et al. Implementation of patient-reported outcome dashboards within the electronic health record to support shared decision-making in serious chronic illness. BMJ Open Qual. 2025;14(1) doi: 10.1136/bmjoq-2024-002837. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Items S1-S2; Tables S1-S2.

